Keyword Connections

drug monitoring

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

36

1 Iatrogenic botulism after botulinum toxin type A injections

2 Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric)

3 A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea

4 Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience

5 A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea

6 A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea

7 Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience

8 Suboxone Treatment and Recovery Trial (STAR-T): Study Protocol for a Randomised Controlled Trial of Opioid Medication Assisted Treatment with Adjunctive Medication Management Using Therapeutic Drug Monitoring and Contingency Management

9 Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus.

10 A new HPLC-MS/MS method for simultaneous determination of Cyclosporine A, Tacrolimus, Sirolimus and Everolimus for routine therapeutic drug monitoring.

11 Therapeutic drug monitoring of cyclosporine and tacrolimus in Myanmar kidney transplant patients

12 Combined approach with therapeutic drug monitoring and pharmacogenomics in renal transplant recipients

13 Better data, better policy and better lives: a call for improved drug monitoring and concerted responses.

14 ["Drug Interaction Stewardship" (DIS) and Therapeutic Drug Monitoring for Anti-infective Treatment in Intensive Care, a Single Centre Observational Study].

15 Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice.

16 Therapeutic Drug Monitoring of Everolimus: A Consensus Report.

17 Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring.

18 [Level of evidence for therapeutic drug monitoring of everolimus].

19 Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus.

20 Development and validation of a high-performance liquid chromatographic method with a fluorescence detector for the analysis of epirubicin in human urine and plasma, and its application in drug monitoring.

21 Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living With HIV: A Narrative Review

22 Pharmacologic treatment of transplant recipients infected with SARS-CoV-2: considerations regarding therapeutic drug monitoring and drug-drug interactions.

23 the routine practice of therapeutic drug monitoring - some of the results of work in the system of chi

24 minimum inhibitory concentration, pharmacokinetics/pharmacodynamics and therapeutic drug monitoring: an integrated approach for multidrug-resistant tuberculosis

25 therapeutic drug monitoring of the newer anti-epilepsy medications

26 population-specific limited sampling strategies for therapeutic drug monitoring of mycophenolic acid

27 early therapeutic drug monitoring for isoniazid and rifampin among diabetics with newly diagnosed tuberculosis in virginia, usa

28 on the road towards strategic application of therapeutic drug monitoring of mycophenolic acid in renal allograft recipients

29 Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review

30 Therapeutic drug monitoring of amikacin in septic patients

31 Therapeutic drug monitoring of anti-infective agents in critically ill patients

32 Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review

33 Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation.

34 The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure.

35 LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring.

36 Bioanalytical Methods for Poly(ADP-Ribose) Polymerase Inhibitor Quantification: A Review for Therapeutic Drug Monitoring.